Advances in Cancer Immunotherapy

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.

Each year SITC offers a series of free regional Advances in Cancer Immunotherapy™ (ACI) programs – with one coming to Boston in October. 

These programs, developed by a team of providers, are CME-, CNE-, CPE- and MOC-accredited, presented by local authorities in tumor immunology and cancer immunotherapy and are FREE for healthcare professionals in the clinical setting, students and patient advocates.

ACI Program - Boston 

Thursday, Oct. 10, 2019 

3:30 – 8:20 p.m. EDT

Courtyard Boston Downtown 275 Tremont Street; Boston, MA 02116

Attendees will leave this program with the ability to:

• Treat patients with FDA-approved immunotherapies
• Interpret new clinical data supporting the use of checkpoint inhibitors, CAR T therapies, cytokines, oncolytic viruses and vaccines
• Identify and manage irAEs
• Employ strategies to overcome operational and reimbursement barriers to incorporating immunotherapy into your practice
• Apply foundational knowledge for clinical implementation of SITC's Cancer Immunotherapy Guidelines
• Anticipate forthcoming immunotherapy trends/treatments/trials and how they impact your patients and practices
• Recognize common and uncommon toxicities in immunotherapy patients and provide solutions/adjustments in treatment to address them

Click here for more information or to register now.